The money will be raised through the Reserve Bank of India's external commercial borrowing channel.
Shares traded at an average price of ₹1,318 per share, representing an up to 11% decrease from Monday's closing price.
Gross NPA for the quarter increased to 2.42% from 2.71% the previous quarter, while net NPA fell to 0.33% from 0.36% in March.
Alembic Pharmaceuticals has got the final approval from USFDA for Dabigatran Etexilate Capsules, 110 mg.
No new positions can be taken in F&O contracts of stocks under the ban period.
The majority of natural gas produced domestically is currently controlled by two price regimes.
Brainbees Solutions raised a total of ₹4,194 crore through the IPO, comprising a fresh issue of ₹1,666 crore and an offer-for-sale of 5.4 crore equity shares
The closing stocks are expected to be significantly greater than they were a year ago, up 39.2% for August and 57% for September.
According to reports, BPCL is examining the land offer and may shortly decide on a single site.
LIC continues to grow faster on new business premiums, but it is the private insurers dominating policies sold
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
